Multicenter open-label single dose study to evaluate safety tolerability and pharmacokinetics of LCZ696 followed by a 52-week randomized double-blind parallel group active-controlled study to evaluate the efficacy and safety of LCZ696 compared with enalapril in pediatric patients from 1 month to
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this study is to find out if the drug LCZ696 is safe and has beneficial effects in children with heart failure who are 1 month to less than 18 years old.
Description
The purpose of this study is to find out if the drug LCZ696 is safe and has beneficial effects in children with heart failure who are 1 month to less than 18 years old.
Details
| Condition | heart failure |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX6694 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.